ADIL
Adial Pharmaceuticals Inc
NASDAQ: ADIL · HEALTHCARE · BIOTECHNOLOGY
$1.55
-0.64% today
Updated 2026-04-29
Market cap
$2.21M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-11.93
Dividend yield
—
52W range
$2 – $30
Volume
0.1M
Adial Pharmaceuticals Inc (ADIL) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | $565.00 | $565.00 | $565.00 | $563.00 | $565.00 | $564.00 | $55106.00 | $60501.00 | $564.00 | $565.00 | $565.00 |
| Gross profit | $-565.00 | $-565.00 | $-565.00 | $-563.00 | $-565.00 | $-564.00 | $-55106.00 | $-60501.00 | $-564.00 | $-565.00 | $-565.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $322107.00 | $146143.00 | $182107.00 | $368459.00 | $3.97M | $5.85M | $8.40M | $1.95M | $1.27M | $3.23M | $2.62M |
| SG&A | $497150.00 | $264664.00 | $813179.00 | $6.62M | $4.28M | $5.07M | $9.34M | $8.91M | $5.62M | $5.06M | $5.18M |
| Operating income | $-819257.00 | $-410807.00 | $-995286.00 | $-6.99M | $-8.24M | $-10.93M | $-19.29M | $-10.86M | $-6.89M | $-8.28M | $-7.80M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-817428.00 | $-410002.00 | $-994354.00 | $-6.98M | $-8.59M | $-10.93M | $-17.69M | $-10.86M | $-7.00M | $-8.28M | $-7.80M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-817993.00 | $-410567.00 | $-994919.00 | $-6.98M | $-8.59M | $-10.93M | $-17.74M | $-10.86M | $-7.00M | $-8.28M | $-7.80M |
| Interest expense | $0.00 | $9643.00 | $144537.00 | $1.17M | $0.00 | $0.00 | $3.61M | $585209.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-817993.00 | $-420200.00 | $-1.14M | $-11.63M | $-8.59M | $-10.86M | $-19.42M | $-12.73M | $-7.00M | $-13.20M | $-7.98M |
| Net income growth (YoY) | — | +48.6% | -171.2% | -920.8% | +26.1% | -26.4% | -78.8% | +34.5% | +45.0% | -88.5% | +39.6% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — |